Nanovision Technology
PrivateLast Round
Series C
Extension
Nov 30, 2024
Est. Valuation
$396.27M
Total Funding Raised
$132.55M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nanovision Technology is a medical device company that specializes in high-speed, high-precision radiation imaging solutions, including static CT systems, X-ray detectors, and medical imaging software.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanovision Technology Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Nanovision Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Nov 30, 2024 | ||||
| Follow-on Offering | Jul 12, 2022 | ||||
| Strategic | Mar 23, 2022 | ||||
| Series C | Nov 11, 2021 | ||||
| IPO Announced | Jun 23, 2021 | ||||
Series C Extension | Feb 1, 2020 |
Nanovision Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Guotai Junan Securities (Hong Kong) Limited | Follow-on Offering |
| China Galaxy Securities Co., Ltd. | Follow-on Offering |
| Hillhouse Investment | Series A |
| Northern Light Venture Capital | Series C |
| Huimei Capital | Series C |
| Legend Capital | Early Funding, Pre Seed |
| HongShan | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2026
Weitao Li joins as Director of Corporate Communications.
- Jun 23, 2021
$55M raised in IPO round.
Nanovision Technology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nanovision Technology's valuation, stock price, and market status.